Vu Skin Systems, Inc. – Trademark Portfolio
Entity Type: 03
Vu Skin Systems, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 9 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VU and VU SKIN SYSTEM. The owner is based in Pittsburgh, PA.
41 Longue Vue Drive
Pittsburgh, PA 15228
Showing of trademarks Trademarks
Trademark Classifications
Vu Skin Systems, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Vu Skin Systems, Inc. have?
Vu Skin Systems, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 5 cancelled.
What trademark classes does Vu Skin Systems, Inc. file in?
Vu Skin Systems, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Vu Skin Systems, Inc.'s most well-known trademarks?
Vu Skin Systems, Inc.'s registered trademark portfolio includes well-known marks such as VU and VU SKIN SYSTEM. These are among 2 currently registered trademarks in the portfolio.
What is Vu Skin Systems, Inc.'s trademark registration success rate?
Vu Skin Systems, Inc. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.